semaglutide cardiovascular outcomes news today HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide and Cardiovascular Outcomes in
Description
Sweetness in the gut Studies in vitro and ex-vivo with isolated human primary cells suggest that there are two temporally distinct pathways that lead to the glucose-stimulated release of GLP-1, similarly to what happens in -cells with the 1st or 2nd phase insulin release
Comment or DM if you want in
Existing Weight Loss Pills Orforglipron is not the only GLP-1 weight loss pills in development
U -1 1 2 4
REMODEL, A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (NCT04865770)
2 (2024): e156, 10.1097/JW9.0000000000000156
